Trial reportScientific reports2017
Brief intervention to promote smoking cessation and improve glycemic control in smokers with type 2 diabetes: a randomized controlled trial.
Trial report in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03800719 (Personalized Support Using Instant Messaging Applications to Increase Smoking Cessation in Smokers Proactively Recruited From Smoking Hotspots in Hong Kong), which is not on this map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Personalized Support Using Instant Messaging Applications to Increase Smoking Cessation in Smokers Proactively Recruited From Smoking Hotspots in Hong Kong: a Pragmatic Randomized Controlled Trial
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Korean Clinical Practice Guideline of Korean Society for Research on Nicotine and Tobacco (KSRNT) and National Evidence-based Healthcare Collaborating Agency (NECA) on Treatment of Tobacco Use 2024.Journal of Korean medical science · 2025Guideline
- Cigarette smoking and risk of albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies.International urology and nephrology · 2018Pooled it
- Trial
- Evidence-based brief cessation advice plus active referral for emergency department patients who smoke: a single-arm, real-world clinical trial.BMC medicine · 2025Trial
- Impact of brief smoking cessation intervention on quitting rate and glycemic control in patients with diabetes: a randomized controlled trial.The Journal of international medical research · 2023Trial
- A general health promotion approach to helping smokers with non-communicable diseases quit smoking: A pilot randomized controlled trial.Frontiers in public health · 2022Trial
- Effectiveness of a Brief Self-determination Theory-Based Smoking Cessation Intervention for Smokers at Emergency Departments in Hong Kong: A Randomized Clinical Trial.JAMA internal medicine · 2020Trial
- Patient empowerment and glycemic control among adults with type 2 diabetes in Madinah, Saudi Arabia: A cross-sectional study.Medicine · 2026Article
- Instant messaging-delivered brief motivational interviewing for noncommunicable disease patients with no intention to quit smoking.NPJ digital medicine · 2026Article
- Effectiveness of nurse-run smoking cessation discussions lasting up to 90 minutes: A systematic review and meta-analysis.Tobacco prevention & cessation · 2026Review
- Prevalence of smoking and factors associated with smoking cessation among diabetic patients in Chongqing, China: A cross-sectional study.Tobacco induced diseases · 2026Article
- Article
- The role of nurses in smoking cessation interventions for patients: a scoping review.BMC nursing · 2024Article
- A multicomponent smoking cessation program for adults with Type 2 Diabetes Mellitus (Contemporary clinical trials communications · 2024Article
- Article
- Effectiveness of intensive stand-alone smoking cessation interventions for individuals with diabetes: A systematic review and intervention component analysis.Tobacco induced diseases · 2023Review
- Helping patients with chronic diseases quit smoking by understanding their risk perception, behaviour, and smoking-related attitudes.PloS one · 2023Article
- A Descriptive Study on Multiple Health-Risk Behaviors among Chinese Adults in Hong Kong.International journal of environmental research and public health · 2022Article
- Article
- Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review.World journal of diabetes · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of the study was to examine the effects of a brief stage-matched smoking cessation intervention group compared with a control group (with usual care) in type 2 diabetes mellitus patients who smoked by randomized controlled trial. There were 557 patients, randomized either into the intervention group (n = 283) who received brief (20- minute) individualized face-to-face counseling by trained nurses and a diabetes mellitus-specific leaflet, or a control group (n = 274) who received standard care. Patient follow-ups were at 1 week, 1 month, 3 months, 6 months, and 12 months via telephone, and assessment of smoking status from 2012 to 2014. Patients smoked an average of 14 cigarettes per day for more than 37 years, and more than 70% were in the precontemplation stage of quitting. The primary outcome showed that both the intervention and control groups had similar 7-day point-prevalence smoking abstinence (9.2% vs. 13.9%; p = 0.08). The secondary outcome showed that HbA1c levels with 7.95% [63 mmol/mol] vs. 8.05% [64 mmol/mol], p = 0.49 at 12 months, respectively. There was no evidence for effectiveness in promoting the brief stage-matched smoking cessation or improving glycemic control in smokers with type 2 diabetes mellitus, particularly those in the pre-contemplation stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.